trihexyphenidyl has been researched along with Acute Post-Traumatic Stress Disorder in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, H | 1 |
| Kaur, R | 1 |
| Jaggi, AS | 1 |
| Bali, A | 1 |
| Sogo, K | 1 |
| Sogo, M | 1 |
| Okawa, Y | 1 |
2 other studies available for trihexyphenidyl and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Beneficial role of central anticholinergic agent in preventing the development of symptoms in mouse model of post-traumatic stress disorder.
Topics: Animals; Behavior, Animal; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; | 2020 |
Centrally acting anticholinergic drug trihexyphenidyl is highly effective in reducing nightmares associated with post-traumatic stress disorder.
Topics: Cholinergic Antagonists; Dreams; Humans; Pharmaceutical Preparations; Single-Blind Method; Stress Di | 2021 |